IL175649A - Process for preparing 3-fluorinated quinolines and novel intermediates in the process - Google Patents

Process for preparing 3-fluorinated quinolines and novel intermediates in the process

Info

Publication number
IL175649A
IL175649A IL175649A IL17564906A IL175649A IL 175649 A IL175649 A IL 175649A IL 175649 A IL175649 A IL 175649A IL 17564906 A IL17564906 A IL 17564906A IL 175649 A IL175649 A IL 175649A
Authority
IL
Israel
Prior art keywords
formula
compound
alkyl radical
linear
group
Prior art date
Application number
IL175649A
Other versions
IL175649A0 (en
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Publication of IL175649A0 publication Critical patent/IL175649A0/en
Publication of IL175649A publication Critical patent/IL175649A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Preparation of 3-fluoro-quinolines (I) (optionally substituted in the 5-, 6-, 7- and/or 8-position) involves heating a corresponding quinoline-3-diazonium tetrafluoroborate (II) in an inert organic solvent. Preparation of 3-fluoro-quinolines of formula (I) involves heating a quinoline-3-diazonium tetrafluoroborate of formula (II) in an inert organic solvent. [Image] R 1 - R 4H or F; linear, branched or cyclic alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); OR 6, NR' 1R'' 1 or COOR a; or phenyl or heteroaryl, both optionally substituted by one or more of the substituents given above or below; R 5H, alkyl or hydroxy-protecting group; R', R'' : H, alkyl or amino-protecting group; R 6H, phenol protecting group or alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); R' 1, R'' 1as for R', R''; or alkyl substituted by 1-3 F, by OR 5 or by NR'R''; and R aH, alkyl or carboxy-protecting group. An independent claim is included for (II) as new compounds.

Description

75649 ,7'ji I 453471 NOVEL METHOD/PROCESS FOR PREPARING 3- FLUORINATED QUINOLINES AND NOVEL INTERMEDIATES (IN THE PROCESS) Pearl Cohen Zedek Latzei P-8756-IL 1 175649/2 The invention relates to a process for preparing fluoroquinolines of formula (I) : wherein Rlf R2, R3 and R4 , which may be identical or different represent : a hydrogen atom; a fluorine atom; a linear, branched or cyclic alkyl radical optionally substituted with one to three fluorine atoms, with a group 0R5 in which R5 represents a linear or branched alkyl radical, a hydrogen atom or a hydroxyl radical -protecting group, or with a group NR'R" in which R' and R", which may identical or different, represent a linear or branched alkyl radical, a hydrogen atom or an amino radical - protecting group; a group 0R6 in which R6 represents a hydrogen atom, a phenol -protecting group or a linear or branched alkyl radical optionally substituted with one to three fluorine atoms, with 0R5 or with NR'R" as defined above; a group NR ' iR"i in which R'x and R"i have the values of R' and R" or represent a linear or branched alkyl radical substituted with one to three fluorine 2 175649/2 atoms, with a group 0R5 as defined above or with a group NR'R" as defined above; group C02Ra, in which Ra represents a hydrogen atom, a linear or branched alkyl radical or a carboxyl radical-protecting group; phenyl radical or a heteroaryl radical, optionally substituted with one or more of the substituents mentioned above, said process comprising: ) subjecting a compound of formula (IV) : wherein Rlt R2 , R3 and R4 are as defined above, to a Hofmann degradation, so as to obtain a compound of general formula (III) : wherein Ri, R2, R3 and R4 are as defined above; b) treating said compound of formula (III) under conditions capable of forming the diazonium salt of general formula (II) : 3 175649/2 wherein Rlf R2, R3 and R4 are as defined above; and c) heating said compound of formula (II) in an inert organic solvent to form the compound of formula (I) .
The Hofmann degradation is carried out with bromine and sodium hydroxide, and also pyridine, in water, at a temperature of approximately 60°C.
The conditions for preparing the diazonium salt consist, for example, in carrying out the process in the presence of an alkali metal salt or of an ester of nitrous acid, in particular of sodium nitrite or of potassium nitrite or of tert-butyl or isobutyl nitrite, and of fluoroboric acid, or in the presence of boron trifluoride-ethyl ether complex, in an appropriate solvent, in particular THF, water or an alcohol, at a temperature between +15 and +20 °C.
In order to convert the compound of formula (II) to a compound of formula (I) , the process is preferably carried out in a solvent such as toluene, xylene, heptane, hexane, a fluorinated solvent such as perfluorohexane , or else a 23680 PCGB 4 chlorinated solvent such as mono- or dichlorobenzene, chlorobutane or methylene chloride.
The heating temperature is preferably between 60 and 100°C and depends, of course, on the solvent used.
A subject of the invention is also a process according to the above, wherein the compound of general formula (IV) obtained by subjecting a compound of formula (V) in which Rlt R2, R3 and R4 are as defined hereinabove, X represents a chlorine atom or a bromine atom and alk represents an alkyl radical containing from 1 to 6 carbon atoms, to the action of a hydrogenolysis agent, and then t that of aqueous ammonia, so as to obtain successively the compound of formula (VI) which may or may not be isolated, and then the compound of formula (IV) .
According to the invention, the two reactions above may be carried out in the reverse order, the compound intermediately formed, and which may or may not be isolated, then being the compound of formula (VII) 23680 PCGB 5 The hydrogenolysis reaction is carried out in an alcohol, in particular ethanol or methanol, in the presence of triethylamine and of a catalyst such as palladium-on-charcoal , by sparging hydrogen into the reaction medium.
It is also possible to carry out the process in dimethylformamide , in the presence of sodium formate and of tetrakis (triphenylphosphine) palladium.
A subject of the invention is also a process according to the above, wherein the compound of formula (V) is obtained by subjecting a compound of formula (VIII) in which Rx, R2, 3 and R4 and alk are as defined hereinabove, to the action of phosphorus oxychloride or phosphorus oxybromide .
The process is preferably carried out without a solvent, at a temperature in the order of about 100°C.
A subject of the invention is also a process according to the above, wherein the compound of formula (IV) is obtained by treating a compound of formula (VIII) , as defined above, with a base, so as to obtain a corresponding acid of formula (IX) 23680 PCGB in which Rl7 R2, R3 and R4 are as defined hereinabove, which is subjected to the action of phosphorus oxychloride or of phosphorus oxybromide, so as to obtain a compound of formula in which Ri, R2 R3, R4 and X are as defined hereinabove, which is subjected to the action of ammonia so as to obtain a compound of formula (VII) as defined above, which is subjected to the action of a hydrogenolysis agent.
The saponification reaction is carried out under conventional conditions known to those skilled in the art, in particular by the action of sodium hydroxide or potassium hydroxide in aqueous medium at reflux temperature.
The action of the phosphorus oxychloride or the phosphorus oxybromide is preferably carried out at the reflux temperature thereof, without solvent.
The hydrogenolysis agent is one of those which were mentioned above.
A subject of the invention is also a process according to the above, wherein the compound of formula (IV) is obtained by heating a compound of formula (XI) 23680 PCGB 7 in which. Ri, R2, 3, R and alk are as defined hereinabove, in the presence of phosphorus pentoxide, so as to obtain a compound of formula (IX) as defined above, and then pursuing the synthesis as described above.
The reaction of the phosphorus pentoxide with the compound of formula (XI) is preferably carried out in a solvent such as nitrobenzene at a temperature in the order of about 120-130°C.
The compound of formula (V) may also be obtained by subjecting a compound of formula (XI) as defined above to the action of phosphorus oxychloride or of phosphorus cxybromide .
The process is preferably carried out without solvent, at a temperature in the order of about 100°C, starting with a compound of formula (XI) in which the sensitive groups on Rlt R2, R3 and R are pre-protected .
The compound of formula (VIII) may be obtained by heating a compound of formula (XI) as defined above, in a solvent with a high boiling point.
The cyclization of the compound of formula (XI) is preferably carried out in diphenyl ether, at reflux temperature or at a temperature similar to the reflux of the latter .
The compound of general formula (XI) is obtained by reacting a compound of general formula (XII) 23680 PCGB 8 in which Rlf R2, R3 and R4 are as defined hereinabove, with a compound of general formula (XIII) alk02C C02alk CH (XIII) in which alk is as defined hereinabove and alki represents a linear or branched alkyl radical which may be. identical or different to alk.
Under preferential conditions, the reaction is carried out without the addition of a solvent, by heating to a temperature of from about 80 to about 120°C.
According to the definitions of Rx, R2, R3 and R4 , it may be desirable, or even necessary, depending on the type of reaction involved, to use compounds in which the substituents are protected. These are in particular the alkyl substituents substituted with OR5 or with NR'R", OR6, NR'iR"i. and C02Ra- A subject of the invention is in particular a process as defined above, wherein use is made of compounds in which the possible sensitive substituents are protected, during the preparation of the compounds of formula (X) from the compounds of formula (IX) and also during the Hofmann degradation producing the compounds of formula (III) from the 23680 PCGB 9 compounds of formula (IV) . According to the invention, the compounds involved are either protected from the beginning of synthesis or just before the critical step is carried out.
The protective groups which may be used and also the use thereof are known to those skilled in the art and described, for example, by T.W. Greene and P.G.M. Nuts, "Protective Groups in Organic Synthesis" (John Wiley & Sons, inc.) .
A subject of the invention is in particular a process according to the above, wherein use is made of compounds in which R1( R2, 3 and R4 , which may be identical or different, represent a hydrogen atom, a fluorine atom, an optionally substituted linear or branched alkyl radical as defined above, or a radical OR6 as defined above.
The subject of the invention is more particularly a process wherein use is made of compounds in which R1; R2, R3 and R4 , which may be identical or different, represent a hydrogen atom, a fluorine atom or a radical 0R6 as defined above, and in particular an alkoxy radical.
Finally, a subject of the invention is a. compound of formula (II) as defined above.
The compounds of formula (I) are intermediate compounds useful in particular in the preparation of compounds having antibacterial activity, described, for example, in applications WO 02/72572 and WO 02/40474.
The following examples illustrate the invention without, however, limiting it.
Example 1 : Preparation of 3 - fluoro-6-methoxyquinoline : A suspension of 1007 g of 6 -methoxy-3 -quinolinediazonium fluoroborate . taken in 9 1 of toluene is heated to 60°C in 85 minutes. A release of gas is observed at 60°C. The reaction medium is then gradually heated further for 90 minutes to 70-72°C. After having been kept at 72°C for 90 minutes, the medium is then gradually heated again to 85°C. After cooling and stirring overnight, 4 1 of ice-cold water are added to the suspension. After having stirred for 15 minutes, 2.5 1 of ethyl acetate are added. After having stirred for 45 minutes, the pH is adjusted to pH = 7-7.5 by 23680 PCGB 10 adding 47% sodium hydroxide (250 ml) . The medium is stirred for 30 minutes and then separated by settling out for 1 hour. The lower aqueous phase is re-extracted with ethyl acetate. The organic phases are combined together and washed with water. The solution is filtered and then concentrated under reduced pressure so as to give 655 g of crude 3-fluoro-6-methoxyquinoline . The crude product is distilled under reduced pressure. The distillation fractions (bp 103-110°C under 1 mbar) containing the expected product are combined together. 498.9 g of 3-fluoro-6-methoxyquinoline (76%) are thus obtained in the form of a white solid which melts at 51-53°C.
Microanalysis : C10H8FNO calculated C 67.79; H 4.55; F 10.72; N 7.91; O 9.03 found C 67.98; H 4.54; N 7.97 NMR spectrum: !fi (300 MHz, (CD3)2SO d6 , δ in ppm) : 3.92 (s: 3H) ; 7.40 (mt : 2H) ; 7.97 (d, J = 10 Hz: 1H) ; 8.13 (dd, J = 10 and 3 Hz: 1H) ; 8.76 (d, J = 3 Hz: 1H) .
Mass spectrum : m = 177 EI m/z = 177 M+' base peak m/z = 134 [M - COCH3]+- DCI m/z .= 178 MH+ base peak 3 -Diazoniumfluoroborate-6-methoxyquinoline : 3-Amino-6-methoxyquinoline (10 g) are suspended in 50 ml of THF and stirred for 15 minutes at 20°C, before being cooled to -15°C. 11.6 g of BF3-etherate are then added. The temperature of the reaction mass is brought to -15°C. After 15 minutes at this temperature, 7.5 g of tert-butyl nitrite at 90% in solution in 25 ml of THF are added over 10 minutes. The suspension is stirred for 1 hour at -15°C, before being brought to +15 °C over a period of one hour. The precipitate is filtered off, washed with hexane and then dried at 15-20°C under constant pressure until a constant weight is obtained. 23680 PCGB 11 14.8 g (94.3%) of 3 -diazoniumfluoroborate- 6-methoxyquinoline are obtained in the form of a yellow solid.
Decomposition temperature: 82 °C 3 -Amino- 6 -methoxyquinoline : 104 kg of a 32% sodium hydroxide solution are added to 341 kg of water. The solution is cooled to 0°C and 22.0 kg of bromine are introduced over 1.5 hours while maintaining the temperature at 0°C. The solution is stirred at this temperature for 1 hour, and then 409 kg of pyridine are introduced over 3 hours at 0°C. 26.5 kg of 6-methoxyquinoline-3 -carboxamide are then added over 50 minutes at 0°C. The reaction medium is kept at this temperature for 2 hours and then gradually heated to 60°C over 1 hour. After maintaining the temperature at 60 °C for 6 hours, the reaction mass is cooled to 20°C and separated by settling out. The aqueous phase (172 kg) is washed with pyridine (60 liters) . The organic phases are pooled (820 kg) and concentrated to dryness under reduced pressure (100-150 mbar) at a maximum of 8 °C. The residue is then taken up with 425 1 of water and 43 1 of ethanol . The suspension obtained is refluxed for 1 hour and then cooled. The product begins to precipitate at a temperature of 65°C. The medium is then cooled to 0-5°C, and kept at this temperature for 2 hours. The precipitate is filtered off, washed with cold water, and then dried at 50-55°C under reduced pressure. 16.5 kg (72.3%) of 3-amino-6 -methoxyquinoline are obtained in the form of a brown solid (HPLC titer = 99.1%), having a melting point of 108-110°C. A second crop of 3.7 kg (13.1%) is obtained from the mother liquors (HPLC titer = 98%) .
NMR spectrum: ¾ (300 MHz, (CD3)2SO d6, δ in ppm) : 3.84 (s: 3H) ; 5.65 (s: 2H) ; 6.97 (dd, J = 9 and 3 Hz: 1H) ; 7.01 (d, J = 3 Hz: 1H) ; 7.08 (d, J = 2.5 Hz: 1H) ; 7.67 (d, J = 9 Hz : 1H) ; 8.29 (d, J = 2.5 Hz : 1H) . 23680 PCGB 12 IR spectrum: (KBr) 3454; 3312; 3204; 1630; 1619; 1607; 1504; 1383; 1251; 1239; 1216; 1167; 1027; 872; 827; 627 and 479 cm"1 Mass spectrum: m = 174 EI m/z = 174 (M+) - base peak m/z = 131 [M - COCH3]+. 6-Methoxyquinoline - 3 -carboxamide : 380 1 of ethanol are added to 49.2 kg of 4 -chloro-3 -ethoxy-carbonyl-6-methoxyquinoline . The suspension is heated at 45°C for 30 minutes and then cooled to 20.°C. 18.65 kg of triethylamine are added under nitrogen, followed by 1.91 kg of palladium-on-charcoal at 5% (at 60% water content) . A stream of hydrogen is passed through under 0.5-0.8 bar at 33 °C for 48 hours. At this time, an HPLC1 control shows that the reaction is complete. The reactor is then vented with nitrogen and the reaction medium is then filtered to remove the catalyst. The filter is then rinsed with ethanol. The filtrate is poured over 750 kg of an aqueous ammonia solution. The reaction medium is then stirred at 25°C over a period of 4 days. The ethanol is then removed by distillation under reduced pressure at a temperature not exceeding 40-45°C. The suspension thus obtained is cooled to 0-5°C and stirred for 3 hours at this temperature. The precipitate is filtered off, washed with cold water, and then dried at 60-65°C under reduced pressure until a constant weight is obtained. 26.5 kg (71%) of 6-methoxyquinoline-3-carboxamide are obtained in the form of a white solid which melts at 93.7-95.7°C (HPLC%NIS= 98.3%).
NMR spectrum: ½ (300 MHz, (CD3)2SO d6 , 5 in ppm) : 3.94 (s: 3H) ; 7.45 (d, J = 3 Hz : 1H) ; 7.52 (dd, J = 9 and 3 Hz: 1H) ; 7.67 (broad s: 1H) ; 8.00 (d, J = 9 Hz : 1H) ; 8.29 (broad s: 1H) ; 8.74 (d, J = 2 Hz : 1H) ; 9.15 (d, J = 2 Hz : 1H) .
IR spectrum: (KBr) 3408; 3330; 3211; 1697; 1626; 1511; 1386; 1321; 1240; 1023; 935; 826 and 693 cm"1 23680 PCGB 13 Mass spectrum: m = 202 EI m/z = 202 [M+] - base peak m/z = 186 [M -NH2] + m/z = 158 [186 - CO] + 4-Chloro-3 -ethoxycarbonyl -6-methoxyquinoline : 132 g of phosphoryl chloride are added, at 25 °C, to 50 g of diethyl 2- [ ( -methoxyphenylamino) methylene] malonate . The reaction medium is stirred for 15 minutes at this temperature, heated to 95-100°C over 45 minutes, and then kept at this temperature for 4 hours. The excess phosphoryl chloride is then removed by heating at 125°C for approximately 2 hours. The mixture is then cooled to 25°C and 125 ml of dichloromethane are added. The medium is then stirred at 25°C for 1 hour, and then run into 900 ml of water, over 30 minutes, while maintaining the temperature below .30°C. The pH is then adjusted, to 7.5-8 by adding 172 g of . a 47% 'Sodium hydroxide solution, while maintaining the temperature at 20-25°C. The 2 phases are separated and the aqueous phase is extracted with dichloromethane. The organic phases are pooled and washed with water. The dichloromethane phase is half-concentrated and 190 ml of ethanol are added. The concentration is continued until the temperature of the reaction mass reaches 82 °C and the vapor temperature reaches 78°C. The reaction mass is cooled to 0-5°C and then kept at this temperature for 2 hours. The precipitate is filtered off, washed with cold ethanol, and then dried at 50°C under reduced pressure. 27.7 g (61%) of 4 -chloro- 3-ethoxycarbonyl -6-methoxyquinoline are obtained in the form of a yellow solid which melts at 93.7-95.7°C.
Titer (HPLC) : 98.0% Diethyl 2- [ (4 -methoxyphenylamino) methylene] malonate : 3.5 kg of p-anisidine are added to 6.25 kg of diethyl ethoxymethylenemalonate at 14°C, over 85 minutes without cooling of the reaction mass. At the end of addition,, the temperature has reached 59°C. The temperature is kept at 23680 PCGB 14 59°C for 30 minutes, and the reaction medium is then heated to 90-95°C and kept at this temperature for 1 hour. The ethanol formed is then removed by distillation at atmospheric pressure and then under 250 mbar. After cooling to 45°C, 8.4 kg of diethyl 2 -[ (4 -methoxyphenylamino) methylene] malonate are recovered in the form of a brown viscous oil, with a quantitative yield.
Titer (HPLC) : 98.3% References : 1/ Description of the analytical conditions: Method: HPLC Column: Hichrom 100 RP18 5μ (250 x 4.6 mm) Flow rate: 1 ml/min Wavelength : 210 nm Injection volume 20 μΐ Eluent 400 ml acetonitrile 600 ml 0.01M sodium dihydrogen phosphate (pH 2.3) 2.88 g/1 sodium dodecyl sulfate.
Inj ection : 20 μΐ of 0.1 mg/ml solution.
Retention time: p-anisidine 12.16 min 2- [ (4 -methoxyphenylamino) methylene] malonic acid diethyl ester 25.0 min 3-ethoxycarbonyl-6-methoxy-4 (1H) -quinolinone 4.15 min 4-chloro-6-methoxyquinoline-3-ethyl carboxylate 24.1 min 6-methoxyquinoline-3 -ethyl carboxylate 16.5 min 6-methoxyquinoline-3-carboxamide 6.0 min 3 -amino- 6 -methoxyquinoline 16.2 min 3-fluoro- 6 -methoxyquinoline 10.0 min 23680 PCGB 15 Example 2 : 3 , 7-Difluoro-6-methoxyquinoline 6.1 g of 3-amino-7-fluoro-6-methoxyquinoline are added, with stirring at a temperature in the region of -5°C, to an aqueous 40% fluoroboric acid solution, and a solution of 2.6 g of sodium nitrite in 5.2 cm3 of water is then added over 20 minutes. The reaction mixture is stirred at a temperature in the region of +3°C for 40 minutes, and then filtered. The solid is washed with an aqueous 40% fluoroboric acid solution at -5°C, then with a mixture of isopropanol and of an aqueous 40% fluoroboric acid solution at -5°C, and then with ethyl ether, spin-filtered to dryness and dried under reduced pressure. 9.95 g of a solid are thus obtained, which are dissolved in 80 cm3 of anhydrous toluene, and this solution is brought to 92 °C for 1 hour with vigorous stirring. After cooling to ambient temperature, 50 cm3 of toluene are added, followed by 80 cm3 of a saturated aqueous solution of sodium hydrogen carbonate. The reaction medium is separated by-settling out, the aqueous phase is extracted with toluene, and the organic phases are pooled, washed with a saturated aqueous solution of sodium chloride, and then dried over sodium sulfate. After filtration and then evaporation to dryness under reduced pressure of the toluene, the residue is chromatographed on a silica column (100 g, particle size 20-46 μττι, eluent : dichloromethane) . The fractions containing the expected product are evaporated to dryness under reduced pressure. 2.28 g of 3 , 7-difluoro- 6 -methoxyquinoline are obtained, in the form of a white solid which melts at 98°C. 3 -Amino-7 -fluoro- 6 -methoxyquinoline : 2.4 cm3 of bromine are added dropwise, over 30 minutes, to a solution of 133 cm3 of aqueous 2N sodium hydroxide solution cooled to 0°C, followed by 111 cm3 of pyridine. 10.1 g of 7-fluoro-6-methoxyquinoline-3-carboxamide are then added to this solution, still at 0°C, and the mixture is stirred at 0°C for 2 hours 30 min. The reaction medium is then allowed to warm back up to ambient temperature, and is then heated with stirring to 60°C for 18 h. It is then allowed to cool down again to ambient temperature, and 100 cm3 of water, 23680 PCGB 16 followed by 100 cm3 of ethyl acetate, are then added. The reaction medium is separated by settling out, the aqueous phase is extracted with ethyl acetate, and the aqueous phases are pooled, washed with water and then dried over sodium sulfate and evaporated to dryness under reduced pressure. 8.25 g of a solid residue are obtained, which residue is triturated in 150 cm3 of isopropyl ether and filtered. The solid is washed with isopropyl ether and then with pentane . After drying, 6.20 g of 3 -amino- 7- fluoro- 6-methoxyquinoline are obtained, in the form of a light brown solid which melts at 153°C. 7 -Fluoro-6-methoxyquinoline-3 -carboxamide : .58 g of sodium formate and 3.16 g of tetrakis- (triphenylphosphine) palladium are added to a solution of 13.9 g of 4-chloro-7-fluoro-6-methoxyquinoline-3-carboxamide in 278 cm3 of dimethylformamide , and this solution is heated under an argon atmosphere at 100 °C for 5 hours. After cooling to ambient temperature, the reaction medium is filtered. The filtrate is concentrated under" reduced pressure so as to obtain 200 cm3 of a solution, to which 600 cm3 of water are added. The precipitate formed is filtered off, washed with water and then dried at 50°C under reduced pressure. The solid obtained is washed with toluene, then twice with ethyl ether, and then with pentane. 10.7 g of 7-fluoro-6-methoxyquinoline-3 -carboxamide are obtained, in the form of a beige solid which melts at 231°C. 4 -Chloro-7-fluoro- 6 -methoxyquinoline-3 -carboxamide : A stirred solution of 15.83 g of 7-fluoro-4 -hydroxy-6-methoxyquinoline- 3 -carboxylic acid in 40 cm3 of phosphoryl chloride is brought to 100 °C for 3 hours. After cooling to ambient temperature, the reaction medium is distilled under atmospheric pressure in order to remove the phosphoryl chloride. The residue is dissolved in 70 cm3 of dichlorornethane , and then ammonia is sparged into this solution, which is kept at 25°C with stirring for 5 hours. The reaction medium is then filtered, and the solid obtained 23680 PCGB 17 is washed with dichloromethane and then dried at 50 °C under reduced pressure. 14.05 g of 4-chloro-7-fluoro-6-methoxy-quinoline-3 -carboxamide are obtained, in the form of an off-white solid which melts at 228°C. 7-Fluoro-4 -hydroxy-6-methoxyquinoline-3 -carboxy1ic acid : A stirred solution of 23.57 g of ethyl 7- fluoro-4 -hydroxy-6-methoxyquinoline-3-carboxylate in 71 cm3 of an aqueous 5N sodium hydroxide solution is brought to 100°C for 3 hours. After cooling to ambient temperature, the reaction medium is acidified by adding 32.5 cm3 of an aqueous 37% hydrochloric acid solution. After addition of 150 cm3 of water, the precipitate obtained is filtered off and the solid is washed with water. After drying in the open air, 22 g of 7-fluoro-4-hydroxy-6-methoxyquinoline-3-carboxylic acid are obtained, in the form of a cream solid which melts at 275°C.
Ethyl 7- fluoro-4 -hydroxy-6-methoxyquinoline-3 -carboxylate : A : stirred solution of 37.75 g of diethyl 2 - [ ( 3 - fluoro-4 - . methoxyphenylamino) methylene] malonate in 170 cm3 of diphenyl ether is brought to 245°C for 3.5 hours. After cooling to ambient temperature, 220 cm3 of cyclohexane are added, and the precipitate thus obtained is filtered off and washed with cyclohexane and then with pentane and is spin- filtered to dryness. 24.10 g of ethyl 7-fluoro-4 -hydroxy- 6 -methoxy-quinoline-3 -carboxylate are obtained, in the form of a solid which melts at 280°C.
Diethyl 2- [ (3 - fluoro- -methoxyphenylamino) methylene] malonate : A stirred mixture of 15.61 g of 3 -fluoro-4 -methoxyaniline and of 24.25 g. of diethyl ethoxymethylenemalonate is brought to 100 °C for 2.5 hours. After cooling to ambient temperature and then evaporation to dryness at 50 °C under reduced pressure, 35 g of diethyl 2 - [ ( 3 -fluoro-4 -methoxyphenylamino) methylene] malonate are obtained, in the form of a beige solid which melts at 63 °C. 23680 PCGB 18 Example 3 : 3 , 8-Difluoro-6-methoxyquinoline By carrying out the process as described in Example 2, but using 2.35 g of 3-amino-8-fluoro-6-methoxyquinoline, 1.35 g of 3 , 8-difluoro-6-methoxyquinoline are obtained, in the form of a white solid which melts at 122°C Characteristics of the synthesis intermediates: 3 -Amino- 8-fluoro- 6-methoxyquinoline : brown solid which melts at 135°C. 8-Fluoro-6-methoxyquinoline-3-carboxamide : beige solid which melts at 248°C. 4-Chloro-8-fluoro-6-methoxyquinoline-3-carboxamide : light brown solid which melts at 220°C. 8-Fluoro~4-hydroxy-6-methoxyquinoline-3-carboxylic acid: beige solid which melts at around 280°C.
Ethyl 8-fluoro-4 -hydroxy- 6-methoxyquinoline-3 -carboxylate : light brown solid which melts at 221°C.
Diethyl 2- [ (2 - fluorp-4 -methoxyphenylamino) methylene] malonate : mass spectrum EI m/z = 311 (M+) . 2-Fluoro-4-methoxyaniline is used at the start.
Example 4 : 3 , 6-Difluoroquinoline By carrying out the process as described in Example 2, but using 3 -amino-6-fluoroquinoline, 3 , 6-difluoroquinoline is obtained, mass spectrum EI m/z = 165 ( +) .
Characteristics of the synthesis intermediates: 3 -Amino- 6 -fluoroquinoline : mass spectrum EI m/z = 162 (M+) . 23680 PCGB 19 6-Fluoroquinolone-3 -carboxamide : mass spectrum EI m/z = 190 (M+) . 4-Chloro-6-fluoroquinoline-3 -carboxamide : mass spectrum EI m/z = 224 (M+) . 4-Hydroxy-6-fluoroquinoline-3 -carboxylic acid: mass spectrum EI m/z = 207 (M+) .
Ethyl 4 -hydroxy- 6 - fluoroquinoline-3 -carboxylate : mass spectrum EI m/z = 235 (M+) .
Diethyl 2- [ (2- fluoro-4 -methoxyphenylamino) methylene] malonate mass spectrum EI m/z = 281 (M+) .
-Fluoroaniline is used at the start.

Claims (16)

- 20 - 175649/2 C L A I M S
1. A process for preparing 3-fluoroquinolines of formula (I) : (I) wherein Ri, R2, R3 and R4, which may be identical or different, represent : a hydrogen atom; a fluorine atom; a linear, branched or cyclic alkyl radical optionally substituted with one to three fluorine atoms, with a group OR5 in which R5 represents a linear or branched alkyl radical, a hydrogen atom or a hydroxyl radical-protecting group, or with a group NR'R" in which R' and R", which may identical or different, represent a linear or branched alkyl radical, a hydrogen atom or an amino radical-protecting group; a group ORe in which R6 represents a hydrogen atom, a phenol-protecting group or a linear or branched alkyl radical optionally substituted with one to three fluorine atoms, with OR5 or with NR'R" as defined above; a group NR'iR"i in which R'i and R"i have the values of R' and R" or represent a linear or branched alkyl radical substituted with one to three fluorine atoms, with a group OR5 as defined above or with a group NR'R" as defined above; - 21 - 175649/2 group C02Ra, in which Ra represents a hydrogen atom, a linear or branched alkyl radical or a carboxyl radical-protecting group; phenyl radical or a heteroaryl radical, optionally substituted with one or more of the substituents mentioned above, said process comprising: subjecting a compound of formula (IV): wherein Ri, R2, 3 and R4 are as defined above, to a Hofmann degradation, so as to obtain a compound of general formula (III) : (HI) wherein Ri, R2, R3 and R4 are as defined above; b) treating said compound of formula (III) -under conditions capable of forming the diazonium salt of general formula (II) : - 22 - 175649/2 wherein Ri, R2, R3 and R4 are as defined above; and c) heating said compound of formula (II) in an inert organic solvent to form the compound of formula (I).
2. The process as set forth in claim 1, wherein the diazonium salt is prepared by the action of an alkali metal salt or of an alkyl ester of nitrous acid and of fluoroboric acid or of the boron trifluoride-ethyl ether complex.
3. The process as set forth in claim 1, wherein the compound of formula (IV) is obtained by subjecting a compound of formula (V) : wherein Ri, R2, R3 and R4 are defined as in claim 1, X represents a chlorine atom or a bromine atom and alk represents an alkyl radical containing from 1 to 6 carbon atoms, to the action of a hydrogenolysis agent, to obtain the compound of formula (VI) : 175649/2 treating the compound of formula (VI) with aqueous ammonia to obtain the compound of formula (IV) .
4. The process as set forth in claim 3, wherein the compound of formula (VI) is not isolated, and . the compound of formula. (V) is subjected successively to hydrogenolysis and then treated with ammonia to form directly the compound of formula (IV).
5. The process as set forth in claim 3, wherein the compoun of formula (VI) is first isolated and then converted t compound of formula (IV) by the action of aqueous ammonia.
6. The process as set forth in claim 1, wherein the compound of formula (IV) is obtained by subjecting a compound of formula ' (V) : wherein Ri, R2, R3 and R4 are defined as in claim 1, X represents a chlorine atom or a bromine atom and alk represents an alkyl radical containing from 1 to 6 carbon - 24 - 175649/2 atoms, to the action of aqueous ammonia, so as to obtain a compound of formula (VII) : wherein Ri, R2, R3 and R4 are as defined in claim 1 and X represents a chlorine atom or a bromine atom, which is subjected to the action of a hydrogenolysis agent so as to obtain the compound of formula (IV).
7. . The process set forth in claim 3, wherein the compound of formula (V) is obtained by subjecting a compound of formula (VIII) : wherein Ri, R2, R3 and R4 defined in claim 1 and alk represents an alkyl radical containing from 1 to 6 carbon atoms, to the action of phosphorus oxychloride or phosphorus oxybromide.
8. . The process set forth in claim 6, wherein the compound of formula (V) is obtained by subjecting a compound of formula (VIII) : - 25 - 175649/2 wherein Ri, R2, R3 and R4 are as defined in claim 1 and alk represents an alkyl radical containing from 1 to 6 carbon atoms, to the action of phosphorus oxychloride or phosphorus oxybromide .
9. . The process as set forth in claim 1, wherein the compound of formula (IV) is obtained by treating a compound of formula (VIII) : wherein Ri, R2, R3 and R are as defined in claim 1 and alk represents an alkyl radical containing from 1 to 6 carbon atoms, with a base, so as to obtain a corresponding carboxylic acid of formula (IX) : - 26 - 175649/2 wherein Ri, R2, R3 and R4 are as defined in claim 1, which is subjected to the action of phosphorus oxychloride or of phosphorus oxybromide, so as to obtain a compound of formula (X) : wherein Ri, R2, R3 and R4 are as defined in claim 1 and X represents a chlorine atom or a bromine atom, which is subjected to the action of ammonia so as to obtain a compound of formula (VII) : wherein Ri, R2, R3 and R4 are as defined in claim 1 and X represents a chlorine atom or a bromine atom, which is subjected to the action of a hydrogenolysis agent to obtain the compound of formula (IV) .
10. The process as set forth in claim 1, wherein optionally all of the sensitive substituents in the compound of formula (IV) are suitably protected. i
11. The process as set forth in claim 9, wherein optionally all of the sensitive substituents in the compound of formula (IX) are suitably protected. - 27 - 175649/2
12. wherein RLF R2, R3 and R , which may be identical or drff^rent, represent a hydrogen atom or a fluorine atom, an optionally substituted linear or branched alkyl radical as defined in claim 1, or a radical 0R6 as defined in claim 1.
13. The process as set forth in claim 9, wherein Ri, R2, R3 and R4, which may be identical or different, represent a hydrogen atom or a fluorine atom, an optionally substituted linear or branched alkyl radical as defined in claim 1, hydrogen as defined in claim 1, or a radical 0R6 as defined in claim 1.
14. The process as set forth in claim 12, wherein Ri, R2, R3 and R4, which may be identical or different, represent a hydrogen atom or a fluorine atom, hydrogen, or a linear or branched alkoxy radical containing from 1 to 10 carbon atoms.
15. The process as set forth in claim 13, wherein Rl R2, R3 and R4, which may be identical or different, represent a hydrogen atom or a fluorine atom, hydrogen, or a linear or branched alkoxy radical containing from 1 to 10 carbon atoms.
16. A compound of formula (II) wherein Ri, R2, R3 and R4 which may be identical or different, represent : a hydrogen atom; a fluorine atom; - 28 - 175649/2 linear, branched or cyclic alkyl radical optionally substituted with one to three fluorine atoms, with a group 0R5 in which R5 represents a linear or branched alkyl radical, a hydrogen atom or a hydroxyl radical-protecting group, or with a group NR ' R " in which R ' and R " , which may identical or different, represent a linear or branched alkyl radical, a hydrogen atom or an amino radical-protecting group; group 0R6 in which R6 represents a hydrogen atom, a phenol-protecting group or a linear or branched alkyl radical optionally substituted with one to three fluorine atoms, with 0R5 or with NR ' R " as defined above; group NR ' iR " i in which R ' i and R " i have the values of R ' and R" or represent a linear or branched alkyl radical substituted with one to three fluorine atoms, with a group OR5 as defined above or with a group NR ' R " as defined above; group C02Ra f in which Ra represents a hydrogen atom, a linear or branched alkyl radical or a carboxyl radical-protecting group; phenyl radical or a heteroaryl radical, optionally substituted with one or more of the substituents mentioned above. P-8756-IL
IL175649A 2003-11-17 2006-05-15 Process for preparing 3-fluorinated quinolines and novel intermediates in the process IL175649A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313384A FR2862301B1 (en) 2003-11-17 2003-11-17 NEW PROCESS FOR THE PREPARATION OF 3-FLUORINATED QUINOLINES
PCT/FR2004/002910 WO2005049575A1 (en) 2003-11-17 2004-11-15 Novel method of preparing 3-fluorinated quinolines

Publications (2)

Publication Number Publication Date
IL175649A0 IL175649A0 (en) 2006-09-05
IL175649A true IL175649A (en) 2011-01-31

Family

ID=34508487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL175649A IL175649A (en) 2003-11-17 2006-05-15 Process for preparing 3-fluorinated quinolines and novel intermediates in the process

Country Status (18)

Country Link
EP (1) EP1687276B1 (en)
JP (1) JP4751333B2 (en)
KR (1) KR20060123161A (en)
CN (1) CN100537540C (en)
AT (1) ATE445605T1 (en)
AU (1) AU2004291376A1 (en)
CA (1) CA2542796C (en)
DE (1) DE602004023640D1 (en)
ES (1) ES2334796T3 (en)
FR (1) FR2862301B1 (en)
HK (1) HK1099020A1 (en)
HR (1) HRP20060168A2 (en)
IL (1) IL175649A (en)
IS (1) IS8423A (en)
MX (1) MXPA06005599A (en)
NO (1) NO20062761L (en)
RU (1) RU2351591C2 (en)
WO (1) WO2005049575A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396934B2 (en) 2003-11-17 2008-07-08 Youssef El-Ahmad Process for preparing 3-fluoroquinolines
CA2750047A1 (en) 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
CN104672131B (en) * 2013-11-27 2017-03-15 中国科学院大连化学物理研究所 A kind of method of 3 fluorine quinolines of synthesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801526B (en) * 1979-03-26 1981-08-26 Robins Co Inc A H 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
DE3620856A1 (en) * 1986-06-21 1987-12-23 Basf Ag 3-CYANCHINOLINE DERIVATIVES
DK273689A (en) * 1988-06-06 1989-12-07 Sanofi Sa 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS
JPH06287187A (en) * 1993-04-02 1994-10-11 Nippon Soda Co Ltd New pyrazole derivative and its abricultural and horticultural germicide
SE0004056D0 (en) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
FR2816618B1 (en) * 2000-11-15 2002-12-27 Aventis Pharma Sa HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2822154B1 (en) * 2001-03-13 2005-10-21 Aventis Pharma Sa QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
TWI275390B (en) * 2002-04-30 2007-03-11 Wyeth Corp Process for the preparation of 7-substituted-3- quinolinecarbonitriles

Also Published As

Publication number Publication date
ES2334796T3 (en) 2010-03-16
CN1894216A (en) 2007-01-10
FR2862301B1 (en) 2007-12-21
HRP20060168A2 (en) 2006-09-30
JP2007511490A (en) 2007-05-10
RU2351591C2 (en) 2009-04-10
WO2005049575A1 (en) 2005-06-02
AU2004291376A1 (en) 2005-06-02
KR20060123161A (en) 2006-12-01
HK1099020A1 (en) 2007-08-03
EP1687276A1 (en) 2006-08-09
CA2542796A1 (en) 2005-06-02
CN100537540C (en) 2009-09-09
MXPA06005599A (en) 2007-01-26
JP4751333B2 (en) 2011-08-17
ATE445605T1 (en) 2009-10-15
NO20062761L (en) 2006-08-17
EP1687276B1 (en) 2009-10-14
CA2542796C (en) 2011-08-02
FR2862301A1 (en) 2005-05-20
RU2006120275A (en) 2008-01-10
IL175649A0 (en) 2006-09-05
IS8423A (en) 2006-04-21
DE602004023640D1 (en) 2009-11-26

Similar Documents

Publication Publication Date Title
US5342944A (en) Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones
HU197324B (en) Improved process for producing quinoline-3-carboxylic acid derivatives of antimicrobial activity
IL175649A (en) Process for preparing 3-fluorinated quinolines and novel intermediates in the process
CN1471532A (en) Process for the preparation of z-alkoxy-6-trifluoromethyl-N-[(C1,2,4] triazolo[1,5-C] pyrimidin-2-yl) benzensulfonamides
EP0990647B1 (en) Process for producing quinolone derivatives
KR20180116371A (en) Process for producing 4-alkoxy-3-hydroxypicolic acid
KR0141482B1 (en) Process for the preparation of o-carboxypyridyl and o-carboxyquinolylimidazolinones
CN111032650A (en) Novel intermediate useful for synthesis of aminopyrimidine derivative, method for preparing same, and method for preparing aminopyrimidine derivative using same
US7396934B2 (en) Process for preparing 3-fluoroquinolines
CA2705512A1 (en) Process
CA2437954C (en) Process for producing quinolinecarboxyaldehyde derivative and intermediate
US6933388B2 (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolones
JP3186897B2 (en) Method for producing 2-amino-5-methyl-pyridine
JPH02178254A (en) Improved method for synthesizing 3-chloro-2,4,5- trifluorobenzoic acid
WO2023102800A1 (en) Synthesis of 5, 7-dichloro-1, 6-naphthyridine
Chen et al. A Versatile Synthesis of Acridine-1, 9-Diones
JPH0616628A (en) Indole derivative
IL103403A (en) 6-fluoro-7-halo-1,2-dihydro-2-oxo-3-quinolinecarboxylic acid derivatives and their preparation
Campbell et al. Trimethylaluminum-Promoted Cyclization of Cyanoenaminones. A Versatile Synthesis of Substituted Pyrazolopyridines
KR890002639B1 (en) Process for preparing quinoline derivatives
KR100390551B1 (en) Method for manufacturing 3-halomethyl-3-cephem-4-carboxylate 1-oxide
JPH09509185A (en) Process for producing 6-aryloxymethyl-1-hydroxy-4-methyl-2-pyridone
JPH07118232A (en) Production of indoloquinone derivative
KR20010040836A (en) Processes and Intermediates Useful to Make Antifolates
CA2149988A1 (en) Synthesis of benzoquinolinones

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees